Show Summary Details
Page of

Involuntary Movements 

Involuntary Movements
Involuntary Movements

Chizoba Umeh

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 September 2021

Choreiform involuntary movements, “dyskinesia,” are a manifestation of chronic levodopa treatment in Parkinson’s disease. Levodopa-induced chorea presents as brief, irregular, non-rhythmic, flowing, involuntary movements. Risk factors for levodopa- induced dyskinesia include younger age of onset of Parkinson’s disease, greater disease severity, higher levodopa dose, longer duration of levodopa treatment, and female gender. Patients can have varying frequency and severity of dyskinesia. Treatment options for patients with disabling dyskinesia include adjusting the levodopa dose and daily dosing schedule, amantadine, intraduodenal levodopa, and deep brain stimulation.

In this chapter, a case of a 69-year-old woman with longstanding Parkinson’s disease on chronic levodopa treatment is discussed, including the disease course, differential diagnosis, workup, and treatment outcome.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.